Serotonin: a platelet hormone modulating cardiovascular disease

J Thromb Thrombolysis. 2021 Jul;52(1):42-47. doi: 10.1007/s11239-020-02331-0. Epub 2020 Nov 5.

Abstract

Cardiovascular diseases and depression are significant health burdens and increasing evidence suggests a causal relationship between them. The incidence of depression among patients suffering from cardiovascular disease is markedly elevated, and depression itself is an established cardiovascular risk factor. Serotonin 5-hydroxytryptamin (5-HT), a biogenic amine acting as a neurotransmitter and a peripheral hormone, is involved in the pathogenesis of both, cardiovascular disease and depression. Novel cardiovascular functions of 5-HT have recently been described and will be summarized in this review. 5-HT has a broad spectrum of functions in the cardiovascular system, yet the clinical or experimental data are partly conflicting. There is further research needed to characterize the clinical effects of 5-HT in particular tissues to enable targeted pharmacological therapies.

Keywords: 5-hydroxytryptamin; Cardiovascular disease; Platelets; Serotonin.

Publication types

  • Review

MeSH terms

  • Blood Platelets
  • Cardiovascular Diseases* / drug therapy
  • Hormones
  • Humans
  • Serotonin*

Substances

  • Hormones
  • Serotonin